Entero Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENTO and other ETFs, options, and stocks.

About ENTO

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. 

CEO
Richard Joel Paolone
CEORichard Joel Paolone
Employees
2
Employees2
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2014
Founded2014
Employees
2
Employees2

ENTO Key Statistics

Market cap
1.72M
Market cap1.72M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
—
Dividend yield—
Average volume
97.51K
Average volume97.51K
High today
$0.3899
High today$0.3899
Low today
$0.36
Low today$0.36
Open price
$0.38
Open price$0.38
Volume
141.28K
Volume141.28K
52 Week high
$3.16
52 Week high$3.16
52 Week low
$0.185
52 Week low$0.185
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.